v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss)/income $ (1,685,306) $ 1,066,894
Adjustments to reconcile net income to net cash provided by operating activities:    
Allowance for credit losses 2,386,938
Amortization of intangible assets 2,918,611 1,957,877
Amortization of right-of-use assets 116,000 36,806
Share-based compensation 469,583 223,933
Investment loss from equity method investment 58,982
Interest expenses on loans from related parties 35,438
Deferred income tax (403,485)
Change in fair value of warrant liabilities (1,390,543) 336,136
Changes in operating assets and liabilities:    
Accounts receivable (13,894,643) (703,149)
Prepaid expenses and other receivables (60,332) 1,028,346
Accounts payable 14,376,127 2,996,498
Accrued expenses and other liabilities 2,148,296 (3,196,882)
Income tax payable (2,164) (216,977)
Deferred tax liabilities 332,626
Lease liabilities (103,287) (10,810)
Net cash provided by operating activities 4,970,215 3,851,298
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of intangible assets (6,300,000) (8,125,000)
Loan to a related party (112,847)
Purchase of long-term investment (61,982)
Net cash used in investing activities (6,474,829) (8,125,000)
CASH FLOWS FROM FINANCING ACTIVITIES    
Deferred offering costs (213,052)
Repayment of loan from a third party (199,582)
Loan from a related party 313,401
Repayment of loans from related parties (429,238)
Cash inflow from reverse recapitalization 1,136,951
Proceeds from PIPE investments 1,190,159 2,600,000
Repayment of sponsor loans (350,000)
Contribution from a non-controlling shareholder 500,000
Net cash provided by financing activities 2,003,560 2,545,079
Effect of exchange rate changes 37,115
Net change in cash 536,061 (1,728,623)
Cash at the beginning of the period 152,051 2,581,086
Cash at the end of the period 688,112 852,463
SUPPLEMENTAL SCHEDULE OF NON-CASH ITEMS    
Lease liabilities arising from obtaining right-of-use assets 788,061 799,450
Net assets acquired from reverse recapitalization 7,504,745
Financing funds received by a third party on behalf of the Group 2,900,000
Conversion from Convertible Promissory Notes 5,020,253
Offering costs recognized as additional paid-in capital $ 1,030,923